322 related articles for article (PubMed ID: 30258436)
21. The Intestinal Microbiota in Inflammatory Bowel Disease.
Becker C; Neurath MF; Wirtz S
ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629
[TBL] [Abstract][Full Text] [Related]
22. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?
Hold GL; Smith M; Grange C; Watt ER; El-Omar EM; Mukhopadhya I
World J Gastroenterol; 2014 Feb; 20(5):1192-210. PubMed ID: 24574795
[TBL] [Abstract][Full Text] [Related]
23. C4B gene influences intestinal microbiota through complement activation in patients with paediatric-onset inflammatory bowel disease.
Nissilä E; Korpela K; Lokki AI; Paakkanen R; Jokiranta S; de Vos WM; Lokki ML; Kolho KL; Meri S
Clin Exp Immunol; 2017 Dec; 190(3):394-405. PubMed ID: 28832994
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Flagellin-Specific Adaptive Immunity Reveals Links to Dysbiosis in Patients With Inflammatory Bowel Disease.
Cook L; Lisko DJ; Wong MQ; Garcia RV; Himmel ME; Seidman EG; Bressler B; Levings MK; Steiner TS
Cell Mol Gastroenterol Hepatol; 2020; 9(3):485-506. PubMed ID: 31790809
[TBL] [Abstract][Full Text] [Related]
25. Isolation of Mycobacterium avium subspecies paratuberculosis reactive CD4 T cells from intestinal biopsies of Crohn's disease patients.
Olsen I; Tollefsen S; Aagaard C; Reitan LJ; Bannantine JP; Andersen P; Sollid LM; Lundin KE
PLoS One; 2009 May; 4(5):e5641. PubMed ID: 19479064
[TBL] [Abstract][Full Text] [Related]
26. Altered Fecal Microbiota in Paediatric Inflammatory Bowel Disease.
Maukonen J; Kolho KL; Paasela M; Honkanen J; Klemetti P; Vaarala O; Saarela M
J Crohns Colitis; 2015 Dec; 9(12):1088-95. PubMed ID: 26351391
[TBL] [Abstract][Full Text] [Related]
27. Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease.
Orel R; Kamhi Trop T
World J Gastroenterol; 2014 Sep; 20(33):11505-24. PubMed ID: 25206258
[TBL] [Abstract][Full Text] [Related]
28. (10
Lee SM; Kim NH; Lee S; Kim YN; Heo JD; Rho JR; Jeong EJ
Molecules; 2019 Sep; 24(18):. PubMed ID: 31540496
[TBL] [Abstract][Full Text] [Related]
29. The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review.
Wark G; Samocha-Bonet D; Ghaly S; Danta M
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33396537
[TBL] [Abstract][Full Text] [Related]
30. The Good and the Bad Side of Heme-Oxygenase-1 in the Gut.
Marelli G; Allavena P
Antioxid Redox Signal; 2020 May; 32(14):1071-1079. PubMed ID: 31826643
[No Abstract] [Full Text] [Related]
31. Probiotics for inflammatory bowel diseases: a promising adjuvant treatment.
Coqueiro AY; Raizel R; Bonvini A; Tirapegui J; Rogero MM
Int J Food Sci Nutr; 2019 Feb; 70(1):20-29. PubMed ID: 29804478
[TBL] [Abstract][Full Text] [Related]
32. Mucosal IgG in inflammatory bowel disease - a question of (sub)class?
Castro-Dopico T; Clatworthy MR
Gut Microbes; 2020 Nov; 12(1):1-9. PubMed ID: 31480888
[TBL] [Abstract][Full Text] [Related]
33. Gut microbiome structure and metabolic activity in inflammatory bowel disease.
Franzosa EA; Sirota-Madi A; Avila-Pacheco J; Fornelos N; Haiser HJ; Reinker S; Vatanen T; Hall AB; Mallick H; McIver LJ; Sauk JS; Wilson RG; Stevens BW; Scott JM; Pierce K; Deik AA; Bullock K; Imhann F; Porter JA; Zhernakova A; Fu J; Weersma RK; Wijmenga C; Clish CB; Vlamakis H; Huttenhower C; Xavier RJ
Nat Microbiol; 2019 Feb; 4(2):293-305. PubMed ID: 30531976
[TBL] [Abstract][Full Text] [Related]
34. Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease.
Potdar AA; Dube S; Naito T; Li K; Botwin G; Haritunians T; Li D; Casero D; Yang S; Bilsborough J; Perrigoue JG; Denson LA; Daly M; Targan SR; Fleshner P; Braun J; Kugathasan S; Stappenbeck TS; McGovern DPB
Gastroenterology; 2021 Feb; 160(3):809-822.e7. PubMed ID: 33160965
[TBL] [Abstract][Full Text] [Related]
35. Fecal microbial composition of ulcerative colitis and Crohn's disease patients in remission and subsequent exacerbation.
Wills ES; Jonkers DM; Savelkoul PH; Masclee AA; Pierik MJ; Penders J
PLoS One; 2014; 9(3):e90981. PubMed ID: 24608638
[TBL] [Abstract][Full Text] [Related]
36. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
37. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
[TBL] [Abstract][Full Text] [Related]
38. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases.
Frank DN; Robertson CE; Hamm CM; Kpadeh Z; Zhang T; Chen H; Zhu W; Sartor RB; Boedeker EC; Harpaz N; Pace NR; Li E
Inflamm Bowel Dis; 2011 Jan; 17(1):179-84. PubMed ID: 20839241
[TBL] [Abstract][Full Text] [Related]
39. The IL-23/IL-17 pathway in inflammatory bowel disease.
Geremia A; Jewell DP
Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):223-37. PubMed ID: 22375527
[TBL] [Abstract][Full Text] [Related]
40. Microbial-host interactions in inflammatory bowel diseases and experimental colitis.
Sartor RB
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():121-32; discussion 132-7, 251-7. PubMed ID: 19710519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
